These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report. Tang Y; Wei L; Wu Z; Xu P; Mo M BMC Neurol; 2023 Jun; 23(1):226. PubMed ID: 37301871 [TBL] [Abstract][Full Text] [Related]
27. Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease. Thaler A; Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Cedarbaum JM; Orr-Urtreger A; Shenhar-Tsarfaty S; Mirelman A J Neurol; 2021 Apr; 268(4):1517-1525. PubMed ID: 33388928 [TBL] [Abstract][Full Text] [Related]
28. Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic. Sardi SP; Cedarbaum JM; Brundin P Mov Disord; 2018 May; 33(5):684-696. PubMed ID: 29704272 [TBL] [Abstract][Full Text] [Related]
29. Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Pachi I; Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Stamelou M; Trapali XG; Papageorgiou SG; Stefanis L Parkinsonism Relat Disord; 2021 Oct; 91():1-8. PubMed ID: 34425330 [TBL] [Abstract][Full Text] [Related]
30. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Alcalay RN; Kehoe C; Shorr E; Battista R; Hall A; Simuni T; Marder K; Wills AM; Naito A; Beck JC; Schwarzschild MA; Nance M Genet Med; 2020 Mar; 22(3):574-580. PubMed ID: 31680121 [TBL] [Abstract][Full Text] [Related]
31. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease. Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961 [No Abstract] [Full Text] [Related]
32. Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease. Thaler A; Shenhar-Tsarfaty S; Shaked Y; Gurevich T; Omer N; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Cedarbaum JM; Orr-Urtreger A; Giladi N; Mirelman A Sci Rep; 2020 Jun; 10(1):9329. PubMed ID: 32518334 [TBL] [Abstract][Full Text] [Related]
33. Genetic testing for Parkinson's disease in clinical practice. Gasser T J Neural Transm (Vienna); 2023 Jun; 130(6):777-782. PubMed ID: 36929227 [TBL] [Abstract][Full Text] [Related]
35. Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations. Grisanti S; Ferri L; Cavallieri F; Fioravanti V; Vincenzi C; Toschi G; Grisendi I; Sabadini R; Paul JJ; Bauer P; Zedde M; Valzania F Mov Disord; 2022 May; 37(5):1117-1118. PubMed ID: 35587629 [No Abstract] [Full Text] [Related]
36. Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Tropea TF; Amari N; Han N; Rick J; Suh E; Akhtar RS; Dahodwala N; Deik A; Gonzalez-Alegre P; Hurtig H; Siderowf A; Spindler M; Stern M; Thenganatt MA; Weintraub D; Willis AW; Van Deerlin V; Chen-Plotkin A J Parkinsons Dis; 2021; 11(2):757-765. PubMed ID: 33492247 [TBL] [Abstract][Full Text] [Related]
37. Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers. Thaler A; Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Shirvan JC; Cedarbaum JM; Orr-Urtreger A; Regev K; Shenhar-Tsarfaty S; Mirelman A J Parkinsons Dis; 2021; 11(3):1285-1296. PubMed ID: 33998549 [TBL] [Abstract][Full Text] [Related]
38. An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease. Lee SJ; Shaw PM; Thornton B; Kumar A; Eizik M; Goldstaub D; Braun T; Teper G; Pai JK; Chodick G; Bienfait K; Levitan D; Beller D; Chris Min K; Jonathan D; Voss T; Fox CS; Aubrey Stoch S; Struyk AF; Vainstein G J Parkinsons Dis; 2022; 12(5):1645-1653. PubMed ID: 35466950 [TBL] [Abstract][Full Text] [Related]
39. Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis. Huang J; Cheng Y; Li C; Shang H Transl Neurodegener; 2022 Apr; 11(1):21. PubMed ID: 35395825 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants. Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]